BETTERLIFE PHARMA INC.: 10-K filed 2016-04-29

Name: BETTERLIFE PHARMA INC.: 10-K filed 2016-04-29
Creator: BETTERLIFE PHARMA INC.

What BETTERLIFE PHARMA INC. reported in its annual report filed 2016-04-29 (fiscal FY 2016): 25 published measures, 48 facts as tagged in accession 0001477932-16-009996.

This filing

Form: 10-K (annual report)
Filed: 2016-04-29
Fiscal period: fiscal FY 2016
Accession: 0001477932-16-009996 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BETTERLIFE PHARMA INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-01-31	106,115	USD
At 2015-01-31	1,265	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-01-31	435,104	USD
At 2015-01-31	55,790	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2016-01-31	-328,989	USD
At 2015-01-31	-54,525	USD
At 2014-01-31	-672,008	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-01-31	71,639	USD
At 2015-01-31	839	USD
At 2014-01-31	935	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-8,578,431	USD	365
2014-02-01 to 2015-01-31	-1,129,004	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-163,942	USD	365
2014-02-01 to 2015-01-31	-47,257	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	240,232	USD	365
2014-02-01 to 2015-01-31	47,321	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-01-31	-12,590,912	USD
At 2015-01-31	-4,012,481	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	77,718,219	shares	365
2014-02-01 to 2015-01-31	11,599,995	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-0.11	USD/shares	365
2014-02-01 to 2015-01-31	-0.1	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-0.11	USD/shares	365
2014-02-01 to 2015-01-31	-0.1	USD/shares	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-01-31	327	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	5,008,360	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-8,592,856	USD	365
2014-02-01 to 2015-01-31	-117,484	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-01-31	103,215	USD
At 2015-01-31	938	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-02-01 to 2015-01-31	64,888	USD	365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	8,592,856	USD	365
2014-02-01 to 2015-01-31	117,484	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-01-31	74,722,100	shares
At 2015-01-31	65,863,766	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-01-31	4,574,647	USD
At 2015-01-31	262,278	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2016-01-31	616,571	USD
At 2015-01-31	224,860	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-8,186,720	USD	365
2014-02-01 to 2015-01-31	-975,054	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	-8,242,311	USD	365
2014-02-01 to 2015-01-31	-975,054	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	961,746	USD	365
2014-02-01 to 2015-01-31	30,607	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	322	USD	365
2014-02-01 to 2015-01-31	409	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2015-02-01 to 2016-01-31	240,232	USD	365

Inspect the source

Entity: BETTERLIFE PHARMA INC. / CIK 0001464165
Captured: 2026-09-20T09:06:34.124Z
SEC response SHA-256: da89258f023cbc29ad1ecdd31014873fa96a7739fba3e7b66a8b80f8715d36cf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001464165.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))